Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    MD bureau
    MD bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.

      • Home
      • MD bureau

      Articles By : MD bureau

      Amgen Door

      Amgen CEO expects 25% of growth to come from Asia in next decade

      MD bureau16 Jan 2020 1:28 PM IST
      SAN FRANCISCO: Biotechnology giant Amgen Inc expects up to a quarter of its growth to come from Asia over the next decade, Chief Executive Officer...
      No discussion on alleged bribes given by pharma firms to doctors at PM Modis meet, claims IPA

      No discussion on alleged bribes given by pharma firms to doctors at PM Modi's meet, claims IPA

      MD bureau16 Jan 2020 12:26 PM IST
      New Delhi: The Indian Pharmaceutical Alliance (IPA) on Wednesday said Prime Minister Narendra Modi had convened a meeting with the healthcare industry...
      Capacit

      Capacit'e Infraprojects bags Rs 407 crore order in Mumbai

      MD bureau16 Jan 2020 11:04 AM IST
      NEW DELHI: Capacit'e Infraprojects on Wednesday said it has bagged an order worth Rs 407 crore for construction of a hospital building in Mumbai....
      Sun Pharma, Rockwell Medical ink licensing pact for Triferic in India

      Sun Pharma, Rockwell Medical ink licensing pact for Triferic in India

      MD bureau16 Jan 2020 10:30 AM IST
      As per the terms of the agreement, Sun Pharma will be the exclusive development and commercialisation partner for Triferic during the term of the...
      Alembic Pharma gets USFDA nod for spasticity drug Tizanidine

      Alembic Pharma gets USFDA nod for spasticity drug Tizanidine

      MD bureau15 Jan 2020 10:15 AM IST
      New Delhi: Drug firm Alembic Pharmaceuticals on Wednesday said it has received final nod from the US health regulator for Tizanidine hydrochloride...
      SEBI exempts Trust from making open offers for Torrent Group Companies

      SEBI exempts Trust from making open offers for Torrent Group Companies

      MD bureau15 Jan 2020 10:00 AM IST
      The trust currently does not hold any shares in these three firms. Pursuant to the scheme of amalgamation, the trust will hold over 71.2 per cent...
      USFDA panel votes against Nektar painkiller

      USFDA panel votes against Nektar painkiller

      MD bureau15 Jan 2020 9:00 AM IST
      New Delhi: Independent advisers to the U.S. Food and Drug Administration on Tuesday unanimously voted against Nektar Therapeutics' opioid painkiller...
      Prev

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok